Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve 1. Audited Financial Statements ....
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has informed the exchanges that its Board of Directors will meet on April 25, 2025 to approve the audited financial statements and financial results (both standalone and consolidated) for the quarter and financial year ended March 31, 2025. The Board will also consider recommending a final dividend, if any, for FY25. The trading window for designated persons and their immediate relatives is already closed from April 1, 2025, until 48 hours after the results are announced. This is a routine pre-results intimation filed under SEBI LODR Regulations 29 and 33 and contains no actual financial figures.
No immediate impact on shareholders — this is simply an advance notice of the upcoming results. Investors should watch April 25 for the actual numbers and any dividend declaration, which could influence sentiment and stock price.